Ilaris, Childhood Arthritis Drug From Novartis, Wins FDA Approval | Biosciencia News | Scoop.it
The multinational pharma manufacturer says the FDA has approved Ilaris for the treatment of juvenile arthritis in patients aged 2 years and older.